Light Chain Bioscience

Risk score

57

Headquarters

Flag of SwitzerlandSwitzerland

Light Chain Bioscience is a product line of Novimmune SA, a firm focused on discovering and developing therapies using bispecific and multispecific antibody formats. The company's proprietary ?? body platform enables the identification of bispecific antibodies that completely preserve the natural sequence and structure of human antibodies. This distinctive feature is valuable for the long-term treatment of patients. In the field of immuno-oncology, Light Chain Bioscience concentrates on selectively targeting the CD47 checkpoint and T cell redirecting strategies.